Chloroflourocarbon- and hydrofluoroalkalane-cromolyn sodium for asthma: the issue of equivalence trials.
P C
PC
Avila
D000335:Aerosol Propellants; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001249:Asthma / Q000188:drug therapy*; D017402:Chlorofluorocarbons; D004205:Cromolyn Sodium / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D006845:Hydrocarbons, Fluorinated; D009330:Nebulizers and Vaporizers; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D013223:Statistics as Topic / Q000379:methods; D013810:Therapeutic Equivalency
D000335:Aerosol Propellants; D018927:Anti-Asthmatic Agents; D017402:Chlorofluorocarbons; D006845:Hydrocarbons, Fluorinated; D004205:Cromolyn Sodium